from bs4 import BeautifulSoup
import base64
import hashlib

html_data = '<p>&nbsp;</p><figure class="image"><img style="aspect-ratio:28/28;" src="data:image/png;base64,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" width="28" height="28"></figure><p>&nbsp;</p><figure class="image"><img style="aspect-ratio:720/850;" src="https://i.namu.wiki/i/VVGxk8g9vg8gX1M-J2XXv-cZoOh03iwUC7rsTj7duyT4w83AyBWwbHoOe_3-Rixx01NvE6lNM9_LnvuwetgI97Se0JyVV4vgofT_fZJEydajEOFLP34gkql0pvRbNu3ciG9WfyhiJkv1WTiB_VdwtA.webp" alt="2025미지" width="720" height="850"></figure>'


soup = BeautifulSoup(html_data, "lxml")

urls = []
figures = soup.find_all("figure", class_="image")
for figure in figures:
    img = figure.find("img")
    src = img["src"]
    if src.startswith("data:image"):
        format, img_data = src.split(";base64,")

        image_type = format.split("/")[-1]

        image_data = base64.b64decode(img_data)
        file_name = f"{hashlib.md5(image_data).hexdigest()}.{image_type}"
        file_path = f"./src/storage/{file_name}"
        with open(file_path, "wb") as f:
            f.write(image_data)
        urls.append(file_path)

idx = 0
for figure in figures:
    img = figure.find("img")
    if img["src"].startswith("data:image"):
        img["src"] = urls[idx]
        idx += 1

print(soup.prettify())


from bs4 import BeautifulSoup

# HTML 데이터 예시
html_data = """
<html><body><h1>HIV/AIDS ADDRESSING THE MENTAL HEALTH NEEDS OF AFFECTED CHILDREN AND FAMILIES</h1><p><strong>Tami D Benton, Anusha Lachman &amp; Soraya Seedat</strong></p><p><img class="image_resized" height="480" src="https://iacapaptextbook2.com/back/storage/zR1tm2HnxDTEWXEJ6N1Hdw_M1.png" style="aspect-ratio:720/480;width:44.58%;" width="720"/></p><p>‘Amelia, 13, (right) and her sister Mamdiuana, 7, inside the door of their house near Mombane (Mozambique). The sisters now live alone, with the support of their community after both of their parents died of AIDS. Community support for HIV/AIDS orphans has become a priority for many communities. Leaders quickly realized that the effects of HIV related illness are felt by entire communities - not only those who are infected with the disease. As a result, community responses to the pandemic are necessary.’</p><p> </p><p>Image and text: Andy Clark, <span style="color:#1700CB;">PhotoSensitive</span></p><hr/><p>This publication is intended for professionals training or practicing in mental health and not for the general public. The opinions expressed are those of the authors and do not necessarily represent the views of the Editor or IACAPAP. This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws of their country of practice. Some medications may not be available in some countries and readers should consult the specific drug information since not all dosages and unwanted effects are mentioned. Organizations, publications and websites are cited or linked to illustrate issues or as a source of further information. This does not mean that authors, the Editor or IACAPAP endorse their content or recommendations, which should be critically assessed by the reader. Websites may also change or cease to exist.</p><p>©<span style="color:#1700CB;">IACAPAP </span>2013. This is an open-access publication under the <span style="color:#1700CB;">Creative Commons Attribution Non-commercial License</span>. Use, distribution and reproduction in any medium are allowed without prior permission provided the original work is properly cited and the use is non-commercial. Send comments about this book or chapter to jmreyATbigpond.net.au</p><p>Suggested citation: Benton TD, Lachman A, Seedat S. HIV/AIDS. Addressing the mental health needs of affected children and families.. In Rey JM (ed), <i>IACAPAP e-Textbook of Child and Adolescent Mental Health</i>. Geneva: International Association for Child and Adolescent Psychiatry and Allied Professions 2013.</p><hr/><figure class="table" style="width:100%;"><table class="ck-table-resized"><colgroup><col style="width:100%;"/></colgroup><tbody><tr><td><p style="margin-left:12.15pt;"><strong>AIDS</strong>: acquired immune deficiency syndrome.</p><p style="margin-left:48.2pt;"><strong>AIDS</strong>-defining clinical condition: a list of diseases associated with AIDS (published by the United States Center for Disease Control and Prevention, CDC).</p><p style="margin-left:48.15pt;"><strong>ARTs</strong>: antiretroviral drugs, term used to describe all medications used to treat HIV disease.</p><p style="margin-left:48.15pt;"><strong>CCR5 antagonists</strong>: antiretroviral medications that bind to the CCR5 receptor on CD4 cells and prevent the HIV virus from</p><p style="margin-left:48.15pt;">entering lymphocytes, thus interfering with infectivity.</p><p style="margin-left:48.15pt;"><strong>CD4</strong>: a glycoprotein found on the surface of helper T-cells which is a receptor for the HIV virus.</p><p style="margin-left:48.15pt;"><strong>Cytotoxic T-lymphocytes (CTLs)</strong>: killer T-cells that destroy cells infected by a virus.</p><p style="margin-left:48.15pt;"><strong>Fusion inhibitors</strong>: class of antiretroviral medications that prevent the HIV virus from fusing</p><p style="margin-left:48.15pt;">with CD4+ cells, thus interfering with replication.</p><p style="margin-left:12.15pt;"><strong>HAART</strong>: highly active antiretroviral therapy.</p><p style="margin-left:12.15pt;"><strong>HIV</strong>: human immunodeficiency virus infection.</p><p style="margin-left:48.15pt;">HIV infects and destroys T-cells, eventually leading to an acquired immune deficiency syndrome (AIDS).</p><p style="margin-left:48.15pt;"><strong>HIV-1 disease</strong>: the most prevalent strain of human immunodeficiency virus.</p><p style="margin-left:48.2pt;"><strong>HIV-associated dementia </strong>(also known as AIDS dementia complex, HIV dementia, and HIV encephalopathy) is a rapidly progressive dementia associated with HIV infection</p><p style="margin-left:48.2pt;">and characterized by cognitive deficits in a variety of domains.</p><p style="margin-left:48.2pt;"><strong>HIV-positive</strong>: refers to individuals who are infected with the HIV virus. HIV-positive denotes the confirmed presence of an HIV infection.</p><p style="margin-left:48.2pt;"><strong>Integrase inhibitors</strong>: antiretroviral medications that prevent viral DNA from integrating with the CD4 cell’s DNA thus preventing replication of the HIV virus.</p><p style="margin-left:48.2pt;"><strong>Non-nucleoside reverse transcriptase inhibitors (NNRTIs)</strong>: antiretroviral drug class that blocks reverse transcriptase of an HIV enzyme by binding to a different site than the NRTI’s, but also results in inhibition of viral replication.</p><p><br/> </p><p> </p><p style="margin-left:39.95pt;"><strong>Nucleoside reverse transcriptase inhibitors (NRTIs)</strong>: antiretroviral drug class that blocks reverse transcriptase of an HIV enzyme and thus inhibits replication of the HIV virus.</p><p style="margin-left:39.95pt;"><strong>Progressive HIV-1 encephalopathy</strong>: a progressive neurological condition resulting from advanced HIV infection or AIDS, characterized by memory loss, slowed movements, and behavioral changes.</p><p style="margin-left:39.95pt;"><strong>Protease inhibitors</strong>: class of antiretroviral medications that blocks activation of an HIV protease enzyme involved in the synthesis of new viral particles.</p><p style="margin-left:39.95pt;"><strong>Reverse-transcriptase inhibitors (RTIs)</strong>: a class of antiretroviral drugs that inhibit the</p><p style="margin-left:39.95pt;text-align:justify;">activity of reverse transcriptase, a viral DNA polymerase that is required for replication of HIV and other retroviruses.</p><p style="margin-left:39.95pt;text-align:justify;"><strong>Viral load (VL)</strong>: The amount of HIV in a sample of blood. Viral load (VL) is reported as the</p><p style="margin-left:39.95pt;">number of HIV RNA copies per milliliter of blood. An important goal of antiretroviral therapy is to suppress a person’s VL to an undetectable level—a level too low for the virus to be detected by a VL test.</p><p style="margin-left:3.95pt;"><strong>Viremia</strong>: presence of virus in the blood.</p></td></tr></tbody></table></figure><p> </p><p> </p><p style="text-align:justify;">Progress in HIV/AIDS prevention and treatment over the last twenty years has been remarkable. A disease that initially resulted in rapid mortality has now become a chronic condition. So much so that an adolescent</p><p style="text-align:justify;">diagnosed with HIV can expect to live 60 years or more and will be more likely to succumb to diseases of aging such as heart disease rather than to their HIV infection (Insel, 2012). The HIV/AIDS pandemic has severely impacted the mental health of children and families worldwide. The World Health Organization (WHO) estimates that about 34 million people were living with HIV by the end of 2010 (WHO, 2011). Many of those affected are women and children. These data, though alarming, do not begin to reflect the impact of this illness on children, families and communities. HIV/AIDS is a biopsychosocial disease whose impact extends far beyond its physical symptoms. Stigma, social and economic factors, and political environment contribute to the burden of HIV/AIDS. Reports describing rates of new cases and the prevalence of HIV infection inform our understanding of the reach of this illness but they do not capture its actual burden. The number of HIV cases is not proportional to the impact of this illness. Efforts to identify cases, to treat HIV and prevent its progression—and in many instances, to decrease the number of new cases—have been effective. However, we have only begun to understand the mental health effects of HIV on children, adolescents and their families. Furthermore, recognition and treatment for those with the double stigma associated with HIV and mental illness has lagged far behind our knowledge about the HIV virus itself. In this chapter, we will describe what is known about psychiatric and neurologic comorbidities associated with HIV disease, psychosocial sequela of the illness in industrialized and in developing nations, and current evidence-based interventions for young people and families coping with this illness.</p><p> </p><p><br/> </p><h2 style="text-align:center;"><span style="color:#41AD49;">EPIDEMIOLOGY</span></h2><p style="text-align:justify;">Despite significant advances in the prevention, detection and treatment of HIV, millions of men, women and children worldwide continue to be newly infected. (see Table I.3.1). While<a href="#_msocom_1">[AL1]</a>  the number of new cases is declining (new HIV infections have been reduced by 59% since 1995) , they remain alarmingly high. UNAIDS epidemiological data reports that in 2022, 1.3 million [1 million–1.7 million] people were newly infected with HIV with women and girls accounting for 46% in 2022(UNAIDS 2023<a href="#_msocom_2"><span style="color:teal;"><u>[AL2]</u></span></a> <a href="#_msocom_3"><span style="color:teal;"><u>[AL3]</u></span></a> ). According to the World Health Organization (WHO), approximately 1.8milion children under the age of 14 were living with HIV, with 150000 children newly infected at the end of 2019<a href="#_msocom_4"><span style="color:teal;"><u>[AL4]</u></span></a> . (WHO). Additionally, an estimated 1.7million adolescents (between 10 and 19years of age) were living with HIV with 190 000 newly infected cases globally. (WHO) Adolescents specifically represent a management challenge, in that they face additional barriers that impact on their abilities to access treatment early, to maintain compliance and the reliance on adult caregivers to facilitate services tailored to their needs. <span style="background-color:white;color:#3C4245;"> </span><s> Approximately 2.5 million adults and children acquired HIV in 2011, 20% lower than the global estimates of new infections reported in 2001. Children accounted for approximately 330,000 of these new cases, a decline of 24% since 2009. At the end of 2011</s>, <s>0.8% of adults aged 15-49 were living with HIV, with considerable variation across regions (see Table I.3.2). The sharpest declines in newly acquired HIV have occurred in the Caribbean and Sub-Saharan Africa. Sub-Saharan Africa, however, accounts for 69% of individuals living with HIV.</s> <s>Despite the continued reduction in new cases of HIV globally, some regions have trended towards higher rates: a 35% increase in HIV infections were observed in the Middle East and North Africa since 2001, reflecting an increase from 27,000 new cases to 37,000 new cases through 2011 (UNAIDS, 2012).</s></p><p style="text-align:justify;"> </p><h3>Perinatal infection</h3><p style="text-align:justify;">Success in the reduction of new HIV infections has occurred principally through the prevention of transmission from mother to child; a 43% decline in vertical transmission has occurred since 2003. Sub-Saharan Africa—the region</p><p> </p><p> <a href="#_msoanchor_1">[AL1]</a><span style="color:black;">I would suggest taking out this table.</span></p><p> <a href="#_msoanchor_2">[AL2]</a><span style="color:black;">Reference is UNAIDS report 2023</span></p><p> <a href="#_msoanchor_3">[AL3]</a><a href="chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https:/www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf">chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf</a></p><p> </p><p><span style="color:black;">Suggest Adding this fact sheet instead of the table 1.3.1</span></p><p> <a href="#_msoanchor_4">[AL4]</a><span style="color:black;">https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/treatment/treatment-and-care-in-children-and-adolescents</span></p><figure class="table" style="width:80.68%;"><table class="ck-table-resized"><colgroup><col style="width:36.19%;"/><col style="width:26.44%;"/><col style="width:35.07%;"/><col style="width:2.3%;"/></colgroup><tbody><tr><td colspan="4" style="background-color:#CDE4EF;border-bottom:2.25pt solid white;border-left-style:none;border-right-style:none;border-top-style:none;height:30.35pt;padding:0cm;vertical-align:top;width:341.75pt;"><p style="margin-left:40px;"><span style="color:black;"><strong>Table</strong> <strong>I.3.1</strong> <strong>Prevalence</strong> <strong>of</strong> <strong>HIV</strong> <strong>and</strong> <strong>new</strong> <strong>infections</strong> <strong>in</strong> <strong>adults</strong> <strong>and</strong> <strong>children</strong></span><a href="#_msocom_1"><span style="color:black;">[AL1]</span></a><span style="color:black;"> </span></p></td></tr><tr><td style="background-color:blue;height:28.45pt;padding:0cm;vertical-align:top;width:140.4pt;"><p style="margin-left:40px;"><span style="color:white;"><strong>Region</strong></span></p></td><td style="background-color:blue;height:28.45pt;padding:0cm;vertical-align:top;width:87.95pt;"><p style="margin-left:40px;"><span style="color:white;"><strong>Living</strong> <strong>with</strong> <strong>HIV</strong> <strong>(prevalence)</strong></span></p></td><td style="background-color:blue;height:28.45pt;padding:0cm;vertical-align:top;width:110.05pt;"><p style="margin-left:40px;"><span style="color:white;"><strong>Newly</strong> <strong>Infected</strong> <strong>with</strong> <strong>HIV</strong> <strong>(incidence)</strong></span></p></td><td rowspan="12" style="background-color:#CDE4EF;height:28.45pt;padding:0cm;vertical-align:top;width:3.35pt;"><p style="margin-left:0cm;"> </p></td></tr><tr><td style="background-color:#D1D3D4;height:18.6pt;padding:0cm;vertical-align:top;width:140.4pt;"><p style="margin-left:40px;"><span style="color:black;">Sub-Saharan Africa</span></p></td><td style="background-color:#D1D3D4;height:18.6pt;padding:0cm;vertical-align:top;width:87.95pt;"><p style="margin-left:40px;"><span style="color:black;">23.5 million</span></p></td><td style="background-color:#D1D3D4;height:18.6pt;padding:0cm;vertical-align:top;width:110.05pt;"><p style="margin-left:40px;"><span style="color:black;">1.8 million</span></p></td></tr><tr><td style="background-color:white;height:18.6pt;padding:0cm;vertical-align:top;width:140.4pt;"><p style="margin-left:40px;"><span style="color:black;">Middle East and North Africa</span></p></td><td style="background-color:white;height:18.6pt;padding:0cm;vertical-align:top;width:87.95pt;"><p style="margin-left:40px;"><span style="color:black;">300,000</span></p></td><td style="background-color:white;height:18.6pt;padding:0cm;vertical-align:top;width:110.05pt;"><p style="margin-left:40px;text-align:center;"><span style="color:black;">37,000</span></p></td></tr><tr><td style="background-color:#D1D3D4;height:18.6pt;padding:0cm;vertical-align:top;width:140.4pt;"><p style="margin-left:40px;"><span style="color:black;">South and South-East Asia</span></p></td><td style="background-color:#D1D3D4;height:18.6pt;padding:0cm;vertical-align:top;width:87.95pt;"><p style="margin-left:40px;"><span style="color:black;">4 million</span></p></td><td style="background-color:#D1D3D4;height:18.6pt;padding:0cm;vertical-align:top;width:110.05pt;"><p style="margin-left:40px;text-align:center;"><span style="color:black;">280,000</span></p></td></tr><tr><td style="background-color:white;height:18.6pt;padding:0cm;vertical-align:top;width:140.4pt;"><p style="margin-left:40px;"><span style="color:black;">East Asia</span></p></td><td style="background-color:white;height:18.6pt;padding:0cm;vertical-align:top;width:87.95pt;"><p style="margin-left:40px;"><span style="color:black;">830,000</span></p></td><td style="background-color:white;height:18.6pt;padding:0cm;vertical-align:top;width:110.05pt;"><p style="margin-left:40px;text-align:center;"><span style="color:black;">89,000</span></p></td></tr><tr><td style="background-color:#D1D3D4;height:18.6pt;padding:0cm;vertical-align:top;width:140.4pt;"><p style="margin-left:40px;"><span style="color:black;">Oceania</span></p></td><td style="background-color:#D1D3D4;height:18.6pt;padding:0cm;vertical-align:top;width:87.95pt;"><p style="margin-left:40px;text-align:center;"><span style="color:black;">53,000</span></p></td><td style="background-color:#D1D3D4;height:18.6pt;padding:0cm;vertical-align:top;width:110.05pt;"><p style="margin-left:40px;text-align:center;"><span style="color:black;">2,900</span></p></td></tr><tr><td style="background-color:white;height:18.6pt;padding:0cm;vertical-align:top;width:140.4pt;"><p style="margin-left:40px;"><span style="color:black;">Latin America</span></p></td><td style="background-color:white;height:18.6pt;padding:0cm;vertical-align:top;width:87.95pt;"><p style="margin-left:40px;"><span style="color:black;">1.4 million</span></p></td><td style="background-color:white;height:18.6pt;padding:0cm;vertical-align:top;width:110.05pt;"><p style="margin-left:40px;text-align:center;"><span style="color:black;">83,000</span></p></td></tr><tr><td style="background-color:#D1D3D4;height:18.6pt;padding:0cm;vertical-align:top;width:140.4pt;"><p style="margin-left:40px;"><span style="color:black;">Caribbean</span></p></td><td style="background-color:#D1D3D4;height:18.6pt;padding:0cm;vertical-align:top;width:87.95pt;"><p style="margin-left:40px;"><span style="color:black;">230,000</span></p></td><td style="background-color:#D1D3D4;height:18.6pt;padding:0cm;vertical-align:top;width:110.05pt;"><p style="margin-left:40px;text-align:center;"><span style="color:black;">13,000</span></p></td></tr><tr><td style="background-color:white;height:29.6pt;padding:0cm;vertical-align:top;width:140.4pt;"><p style="margin-left:40px;"><span style="color:black;">Eastern Europe and Central Asia</span></p></td><td style="background-color:white;height:29.6pt;padding:0cm;vertical-align:top;width:87.95pt;"><p style="margin-left:40px;"><span style="color:black;">1.4 million</span></p></td><td style="background-color:white;height:29.6pt;padding:0cm;vertical-align:top;width:110.05pt;"><p style="margin-left:40px;text-align:center;"><span style="color:black;">140,000</span></p></td></tr><tr><td style="background-color:#D1D3D4;height:18.6pt;padding:0cm;vertical-align:top;width:140.4pt;"><p style="margin-left:40px;"><span style="color:black;">Western and Central Europe</span></p></td><td style="background-color:#D1D3D4;height:18.6pt;padding:0cm;vertical-align:top;width:87.95pt;"><p style="margin-left:40px;"><span style="color:black;">900,000</span></p></td><td style="background-color:#D1D3D4;height:18.6pt;padding:0cm;vertical-align:top;width:110.05pt;"><p style="margin-left:40px;text-align:center;"><span style="color:black;">30,000</span></p></td></tr><tr><td style="background-color:white;height:18.6pt;padding:0cm;vertical-align:top;width:140.4pt;"><p style="margin-left:40px;"><span style="color:black;">North America</span></p></td><td style="background-color:white;height:18.6pt;padding:0cm;vertical-align:top;width:87.95pt;"><p style="margin-left:40px;"><span style="color:black;">1.4 million</span></p></td><td style="background-color:white;height:18.6pt;padding:0cm;vertical-align:top;width:110.05pt;"><p style="margin-left:40px;text-align:center;"><span style="color:black;">51,000</span></p></td></tr><tr><td style="background-color:#D1D3D4;border-bottom:2.25pt solid white;border-left-style:none;border-right-style:none;border-top-style:none;height:18.45pt;padding:0cm;vertical-align:top;width:140.4pt;"><p style="margin-left:40px;"><span style="color:black;">Global</span></p></td><td style="background-color:#D1D3D4;border-bottom:2.25pt solid white;border-left-style:none;border-right-style:none;border-top-style:none;height:18.45pt;padding:0cm;vertical-align:top;width:87.95pt;"><p style="margin-left:40px;"><span style="color:black;">34 million</span></p></td><td style="background-color:#D1D3D4;border-bottom:2.25pt solid white;border-left-style:none;border-right-style:none;border-top-style:none;height:18.45pt;padding:0cm;vertical-align:top;width:110.05pt;"><p style="margin-left:40px;"><span style="color:black;">2.5 million</span></p></td></tr><tr><td colspan="4" style="background-color:#CDE4EF;height:13.2pt;padding:0cm;vertical-align:top;width:341.75pt;"><p style="margin-left:40px;"><span style="color:black;">Source: </span><span style="color:#1700CB;">UNAIDS (2012)</span></p></td></tr></tbody></table></figure><p style="margin-left:6.15pt;text-align:justify;">burdened with more than 90% of the children with HIV globally—saw a 24% reduction in new cases from 2009 to 2011. Declines have also been achieved in the Caribbean, Oceania, Asia, Latin America, Eastern Europe and Central Asia. There has been no reduction in newly infected children in the Middle East and North Africa (UNAIDS, 2012). Globally in 2022, 82% of pregnant people with HIV had access to ART treatments to prevent perinatal transmission of HIV to their infants<span style="color:black;">.</span></p><p style="margin-left:6.15pt;text-align:justify;">Prenatal detection of HIV-infected women and highly active antiretroviral therapies (HAARTs) have produced significant reductions in new cases of congenitally acquired HIV. Use of HAARTs has resulted in decreased mortality in children acquiring HIV through vertical transmission. In many countries, children who were born with HIV are living into young adulthood and many are working, pursuing higher education and starting their own families (Donenberg &amp; Pao, 2005).</p><h3>Youth</h3><p style="margin-left:6.15pt;text-align:justify;">New infections are highest among older adolescents and young adults. Young women account for more than 60% of all young people living with HIV worldwide<a href="#_msocom_1">[LAD[1]</a> <a href="#_msocom_2">[LAD[2]</a> . (refer to the UNICEF resource on Children and Adolescents living with HIV). This number is even higher in Sub Saharan Africa (71%). In 2010, adolescents aged 15-24 accounted for 42% of new HIV infections in people 15 years and older. Globally, women in the 15-24 years age group are infected at twice the rate of young men and account for 22% of all new HIV infections and 31% of new infections in Sub Saharan Africa. While new infections remain high, there has been progress in 21 of 24 countries that report HIV prevalence, especially in sub Saharan Africa. Women and girls are disproportionally burdened by HIV disease in part related to gender inequality and gender based violence in many countries. For example, rates of forced sex among adolescent girls younger than 15 years have been estimated at 11% to 48% globally (UNICEF, 2011).</p><figure class="image"><img height="685" src="https://iacapaptextbook2.com/back/storage/rzw20zGmCJGGhYa1OMUlrA_image.png" style="aspect-ratio:1219/685;" width="1219"/></figure><h2>Deaths due to HIV</h2><p>More than 20 million people are estimated to have died from HIV/AIDS since the discovery of the virus in 1981 (UNAIDS, 2004). The number of deaths related to AIDS began to decline during the 1st decade of the 21st century due to greater public education, a decline in new infections, and broader availability of antiretroviral drugs. The rate of AIDS-related deaths continues to decline. In 2019, an estimated 100 000 children died from AIDS-related illnesses The WHO reports that an alarming 50% of children with HIV are likely toe die before the ag of 2 without access to early testing or access to antiretroviral treatment.(WHO,2022) <s>In 2011, 1.7 million people died from AIDS-related causes worldwide compared with 2.3 million in 2005 (UNAIDS, 2012). With access to antiretroviral drugs, AIDS has become a chronic condition, even in poorly resourced, hyper-endemic areas (UNAIDS, 2012).</s></p>
"""

soup = BeautifulSoup(html_data, "lxml")

print(html_data.replace('"', '\\"'))
